India ratified the Cartegena Protocol in January 2003, and as a result, the Biotechnology Regulatory Authority of India (BRAI) was proposed to ensure the protection of biodiversity from GMOs.
The Genetic Engineering Approvals Committee is currently responsible for approving genetically engineered products..
Under the Biosafety Research programme, main emphasis is given to facilitate the implementation of biosafety procedures, rules and guidelines under Environment (Protection) Act 1986 and Rules 1989 to ensure safety from the use of GMOs and products thereof in research and application to the users as well as to the Jun 1, 2020.
The purpose of IBSC, IASST is to implement the rules, regulations and guidelines to monitor the biosafety aspects of research, large-scale experiments/production/field release, exchange (inter-state and inter-institutional supply/receipt within India), import and export activities carried out in IASST (and other .
May be covered under the rules.
India is a signatory to the Cartagena Protocol on Biosafety (CPB), however, the definition of modern biotechnology, as in CPB is yet to be adopted in the national regulations.
The regulatory authorities review and take into account the experience by other countries in dealing with new technologies.
Biosafety regulations in India are defined under the 1986 Environment Protection Act, with implementation broadly distributed between the Ministry of Science and Technology and the Ministry of Environment, Forest, and Climate Change (MOEFCC).
These regulations have three aims:.
Rules 1989 assigns biosafety governance to two separate ministries—the Ministry of Science and Technology and the Ministry of Environment, Forest, and Climate Change (MOEFCC).
These rules apply over three different phases—pre-research, research, and commercial release.
Overview of genetically modified food in Asia
